Marvin Slosman

Marvin Slosman

Chief Executive Officer at INSPIREMD, INC.

Net worth: 3 M $ as of 2026-05-30

62 year
Health Technology
Consumer Services
Distribution Services

Profile

Marvin L.
Slosman
is Chief Executive Officer & Director at InspireMD Ltd. since 2019, President, Chief Executive Officer & Director at InspireMD, Inc. since 2020, and Independent Director at BioCardia, Inc. starting in 2025.
Former roles include Chief Executive Officer at Ovalum Ltd., Chief Executive Officer at Phormax, Inc. from 2000 to 2001, Chief Executive Officer at Ovalum Vascular Ltd. from 2008 to 2010, Chief Commercial Officer & Senior EVP at eMerge Interactive, Inc. from 1998 to 2000, President at Itamar Medical, Inc. from 2010 to 2014, and Chief Operating Officer at Medcura, Inc. in 2019.
Education includes an MBA from The University of Chicago and undergraduate studies at The University of Alabama.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-11 3,556,658 ( 7.59% ) 3 M $ 2026-05-30

Marvin Slosman active positions

CompaniesPositionStart
INSPIREMD, INC. Chief Executive Officer 2019-12-31
BIOCARDIA, INC. Director/Board Member 2025-12-01
Chief Executive Officer 2019-11-30

Former positions of Marvin Slosman

CompaniesPositionEnd
Chief Operating Officer 2019-11-30
President 2014-04-30
Chief Executive Officer 2010-11-30
Chief Executive Officer 2001-06-30
Corporate Officer/Principal 1999-12-31
See the detail of Marvin Slosman's experience

Training of Marvin Slosman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Distribution Services

Health Technology

Technology Services

Electronic Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Marvin Slosman
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!